Andrew Saunders
Chief Tech/Sci/R&D Officer at CellCentric Ltd.
Andrew Saunders active positions
| Companies | Position | Start | End |
|---|---|---|---|
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Andrew Saunders
Former positions of Andrew Saunders
| Companies | Position | Start | End |
|---|---|---|---|
| REDX PHARMA PLC | Chief Tech/Sci/R&D Officer | 2018-01-21 | 2021-02-28 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 2005-04-30 | 2007-04-08 |
| Linden Oncology Ltd. | Chief Executive Officer | - | - |
| LYTIX BIOPHARMA | Chief Tech/Sci/R&D Officer | 2015-01-18 | - |
Training of Andrew Saunders
| Trinity College Dublin | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 2 |
| Ireland | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Health Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| REDX PHARMA PLC | Health Technology |
| Private companies | 3 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Linden Oncology Ltd. |
- Stock Market
- Insiders
- Andrew Saunders
- Experience
